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INTRODUCTION
Interferential current (IFC) is widely used in
conjunction with other therapies to manage
musculoskeletal pain. IFC uses two medium
frequency carrier currents which interfere deeper in
tissues, producing an amplitude modulated
frequency (AMF). The interference creates the effect
of low frequency stimulation with less discomfort for
patients compared to direct low frequency
stimulation. The predominant proposed mechanisms
of analgesia include the gate control theory of pain
and endogenous opioid production. Since previous
systematic reviews have found a lack of studies
examining the independent treatment effects of IFC,
this study reviewed the isolated effects of IFC
compared to control groups.
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The initial search yielded 285 results with 10 eligible
studies adhering to inclusion and exclusion criteria,
published from 2011-2016. Participants across
studies included healthy individuals with
experimentally induced pain and patients with the
following diagnoses: chronic low back pain, carpal
tunnel syndrome, shoulder hemiplegia, and knee
osteoarthritis. Outcome measures included
subjective pain reports such as the visual analog
scale (VAS) or the numeric pain rating scale,
objective physiological measurements such as
pain-free ROM or a 15 meter walk test, pain
behavior assessments such as medication use, and
functional outcome measures such as the

DISCUSSION

Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC). These 10 studies
were analyzed with a PEDro scale: scores ranged
from five through nine, with a mean value of seven.
All nine RCTs that used a carrier frequency of 4,000
Hz reported a positive effect of IFC: seven reported
a reduction in a measure of pain and two reported a
decrease in use of pain medication. One RCT
reported no significant effect of IFC when using a
carrier frequency of 2,000 Hz. Four of the 10 RCTs
evaluated long-term effects: three RCTs found
significant lasting benefits, while one RCT found no
significant long term improvements.
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Figure. Application of IFC

PURPOSE
The purpose of this study was to conduct a
systematic review of existing literature addressing
the potential effectiveness of IFC as an adjunctive
biophysical agent for treating musculoskeletal pain.

METHODS
CINAHL, PubMed, Cochrane Library, PEDro,
SportDISCUS, and CENTRAL were searched
between November 2016 and February 2017 with
the following terms: interferential current,
interferential therapy, interferential electrical
stimulation, pain, and analgesia. Articles met
inclusion criteria if they were randomized controlled
trials (RCT) that had IFC as an intervention and an
assessment of pain as an outcome measure.
Studies were excluded if they were duplications, had
a publication date prior to 2009, were not published
in English, used thermal induced pain in healthy
subjects, if the effects of IFC were not tested in
isolation of other treatments, or if no form of a
control group was used.

Atamaz et al, 2012
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CLBP
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IFC: 4 kHz
TENS: 100 Hz
Splint therapy: worn during
night sleep
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Shoulder
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30
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Treatment
Duration

Trial Groups

Knee OA

Outcome
Measures

There was no significant difference between groups for pain intensity
at rest or with movement, but both treatment groups had significantly
12 sessions x 30 ii, iv, v, vi, vii, xv, lower frequeny of pain medication usage. The 1 kHz IFC group had
significantly improved pressure pain threshold and temporal
minutes
xviii
summation. There was no significant difference between the groups
at 4 month follow up.
1 session x 30
minutes

IFC significantly reduced pain intensity and pressure pain threshold.
iv, vi, xxiii, xxi,
Enhanced therapeutic alliance significantly increases the positive
xxii
effects of IFC.

IFC & TENS: 15
sessions x 20
vii, x, xii, xiii-a,
minutes
xiii-b
Splint therapy: 3
weeks
1 session x 20
minutes

IFC: Placebo, 4 kHz

IFC: Placebo, 4 kHz
15 sessions x 20
TENS:Placebo, 80 Hz
minutes
SWD: Placebo, 27.12 MHz,

iv, v, xii

vii, ix, xv, xvi,
xix, xx, xxv

vi-a, vi-b, vi-c,
15 sessions x 20 ix, xiii, xv, xxiv,
minutes
xx-a, xx-b, xxc, xix

Gundog et al, 2012
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CLBP

IFC: 4 kHz
TENS: 20 Hz
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40
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pressure induced

IFC: Placebo, 4 kHz
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3 sessions x 30
minutes

vi

14

Healthy,
pressure &
temperature
induced

IFC: 2 kHz
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1 session x 15
minutes

ii, vii, vii
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Key Findings

IFC was significantly more effective than splint therapy for the
following measures: VAS, mMDL, and mSNCV. IFC was significantly
more effective than TENS for the following measures: VAS, symptom
severity, functional capacity, mMDCL, and mSNCV. Outcome
measures were evaluated three weeks post-treatment completion.
IFC significantly reduced pain during movement and increased painfree PROM for shoulder flexion, abduction, IR, and ER.
All treatment groups had signitificant decreases in pain
assessments. The IFC treatment group had significantly lower
paracetamol intake at 1, 3, and 6 months with no other significant
differences between groups.
All treatment groups had significant improvements on all outcome
measures except for knee AROM. These improvements remained
significant at 1 month follow up. There was no significant difference in
improvement between the treatment groups.
IFC significantly increased pressure pain threshold. There was no
significant difference between groups for isometric peak torque.
IFC was significantly more effective at reducing pain, disability, and
medicine usage than controls. There was no significant difference
between IFC and TENS.
IFC significantly decreased pressure pain threshold.

IFC significantly reduced the pain threshold to cold. There was no
significant difference between groups for pressure pain threshold.

Abbreviations: CLBP, chronic low back pain; CTS, carpal tunnel syndrome; DOMS, delayed onset muscle soreness; OA, osteoarthritis; TA, therapeutic alliance.

Table 2. Outcome Measures
Pain

Activities and Participation

i

Brazilian McGill Pain Questionnaire

xiv

Boston Carpal Tunnel Syndrome Questionnaire (BCTQ)

ii

Conditioned Pain Modulation

xv

Medication Use

iii

Duration of Analgesia

xvi

Nottingham Health Profile (NHP)

iv

Numeric Rating Scale (pain intensity at rest)

xvii

Roland Morris Disability Questionnaire (RMDQ)

v

Numeric Rating Scale (pain intensity with movement)

xviii Sit to Stand

vi

Pain Pressure Threshold

xix

Time to Walk 15 Meters

vii

Visual Analog Scale (VAS)

xx

Western Ontario and McMasters Osteoarthritis Index (WOMAC)

Body Structures and Function

Treatment Evaluation

viii

Hamstring Isometric Peak Torque

xxi

Credibility and Expectancy Questionnaire (CEQ)

ix

Knee Active ROM

xxii

Global Rating Scale

x

Median Nerve Motor Distal Latency (mMDL)

xxiii Pain Rehabilitation Expectations Scale (PRES)

xi

Median Sensory Nerve Conduction Velocity (mSNCV)

xxiv Treatment Effectiveness

xii

Pain-Free Passive ROM

xxv VAS of Satisfaction of Treatment Experience

xiii

Swelling and Synovial Effusion

In this systematic review, including 10 randomized
controlled trials, totaling 898 participants, IFC was
found to be effective in the immediate management
of musculoskeletal pain.
Carrier frequency, as opposed to AMF, may be the
more dominant analgesic parameter. Four thousand
Hz is the most commonly used carrier frequency. All
studies included that used a carrier frequency of
4,000 Hz reported an immediate reduction in pain or
a decrease in use of pain medication. Pereira et al,1
when using a carrier frequency of 2,000 Hz, found
that IFC did not significantly alter pain pressure
threshold, and in fact, reduced pain threshold to
cold. Correa et al2 reported that both the 1,000 and
4,000 Hz groups had no significant alterations in
pain intensity, but did have significantly lower rates
of pain medication usage. In addition, the 1,000 Hz
group had significant improvement on the
physiological pain parameters of temporal
summation and pain pressure threshold (PPT).
Therefore, while a carrier frequency of 4,000 Hz has
been shown to be effective for pain management,
further studies are warranted to examine the
effectiveness of other carrier frequencies.
Despite a lack of evidence, many authors regard
AMF as the most relevant IFC parameter. Gundog
et al3 compared the effectiveness of different AMFs
and found no significantly different analgesic effects.
Future research addressing the potential physiologic
effects of varying the AMF and the associated
clinical implications is needed.
Long term follow-ups had mixed results. Three
studies3-5 found significant improvements at three
weeks, one month, and six months, respectively.
One study2 found no significant difference at four
months. Further research regarding both the long
term effectiveness and the immediate duration of
pain relief based on various IFC parameters is
needed.

CONCLUSIONS
The reviewed studies support use of IFC in the
treatment of musculoskeletal pain. More research is
needed to determine the optimal parameters and
evaluate long-term effectiveness.

CLINICAL RELEVANCE
Current evidence supports utilization of IFC as an
effective adjunctive tool for in-clinic palliative
intervention in the short-term management of
musculoskeletal pain, which may help improve
functional outcomes and reduce patient use of pain
medications.

